University of Crete (UOC)
Study of the structural and biochemical properties and the regulatory mechanisms of human glutamate dehydrogenases
Abstract
dc:descriptionIntroduction : Glutamate dehydrogenase (GDH) is a mitochondrial enzyme that catalyzes the reversible interconversion of L-glutamate and α-ketoglutarate, thereby linking amino acid metabolism with the tricarboxylic acid cycle, cellular energy balance, and nitrogen homeostasis. In humans, two functional GDH isoenzymes exist: hGDH1, encoded by the ubiquitously expressed GLUD1 gene, and hGDH2, encoded by the X-linked GLUD2 gene. The latter arose through retrotransposition during primate evolution and exhibits a restricted tissue distribution, primarily in the brain, testis, and kidney. Despite sharing approximately 97% amino acid sequence identity, the two isoenzymes display markedly distinct regulatory and enzymatic properties. Importantly, genetic variants affecting GDH activity have been implicated in metabolic disorders, neurodegenerative diseases, and neoplastic processes. Understanding the structural and evolutionary basis of hGDH2 regulation is therefore essential for elucidating its physiological role and pathological significance. Aims : The primary aim of this study was to elucidate the structural, biochemical, and evolutionary mechanisms underlying the distinctive regulatory properties of human GDH isoenzymes, with emphasis on hGDH2. Specific objectives were: to characterize structure/function relationships responsible for hGDH2’s low basal activity, resistance to GTP inhibition, and regulation by ADP and L-leucine to investigate the functional evolution of hGDH2 through reconstruction and analysis of evolutionary intermediates to identify potential isoenzyme-specific regulators through in silico screening and enzymatic validation. Methods Recombinant wild-type hGDH1, hGDH2, and selected evolutionary variants were expressed in SF9 insect cells using a baculovirus expression system. Proteins were purified through sequential ammonium sulfate precipitation followed by hydrophobic interaction and hydroxyapatite chromatography. Enzymatic activity was assessed using kinetic assays measuring basal activity, allosteric regulation by ADP, GTP, and L-leucine, thermal stability, and sensitivity to steroidal inhibitors. Computational analyses included AlphaFold-based structural prediction, mutational and intramolecular interaction analysis, and molecular docking of candidate regulatory compounds. Selected docking hits were further evaluated using kinetic assays. Results: AlphaFold-predicted models closely matched experimentally determined GDH structures, enabling reliable reconstruction of the structural evolution of GDH2. Comparative analyses revealed that the earliest evolutionary step following GLUD2 emergence represented the most critical divergence toward the modern hGDH2 phenotype. Functional characterization of ancestral (1st evolutionary step) and primate (Gibbon) GDH2 variants demonstrated that resistance to GTP inhibition and strong ADP-mediated activation were established early during evolution. In contrast, reduced basal activity, increased heat lability, and enhanced sensitivity to steroid-mediated inhibition emerged at later evolutionary stages. Docking-based screening identified several dicarboxylic acid compounds with favorable predicted pharmacokinetic properties; however, enzymatic assays did not reveal strong inhibitory activity under the conditions tested. Discussion: This study provides an integrated structural and functional framework explaining how a small number of coordinated amino acid substitutions conferred distinct regulatory properties upon hGDH2 during primate evolution. Early acquisition of GTP resistance and ADP responsiveness suggests adaptive tuning of GDH2 to energy-demanding cellular environments, particularly in the brain. Later-emerging features, including low basal activity and thermal lability, likely further refined isoenzyme regulation. Although no potent hGDH2-specific inhibitors were identified, the findings highlight critical regulatory regions that may serve as future therapeutic targets. Overall, this work advances understanding of GDH isoenzyme specialization and its relevance to human metabolism and disease.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Litso, Ionela
- Λίτσο, Ιονέλα
Subjects
dc:subject × 14Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61023